The prevalence and the emergence of distinct phenotypic variants appear to be correlated with different stages of infection. Thus, the asymptomatic phase is characterized by the inability to isolate HIV in culture or by the presence of slowly replicating nonsyncytium-inducing (NSI) isolates. In contrast, highly replicating syncytium-inducing (SI) variants emerge in 50% to 60% of HIV-seropositive (HIV') individuals in the progression of HIV infection'.'; the emergence of these viral variants is related to rapid CD4' T-cell depletion and progression to acquired immune deficiency syndrome (AIDS).' Progression of HIV infection is also associated with impairment of cell-mediated immunity (CMI), which has both in vivo and in vitro correlates. Thus, the inability to develop delayed type hypersensitivity reactions (DTH) to ubiquitous Milano. Padiglione L.I. T.A.. Ospedale Luigi Sacco, Miluno; Clinicu Malarrie Infettive, Ospedale Luigi Succo, Miluno; and lstituto Progetto AIDS 1994 and VI11 Progetto AIDS 1995" NO. 8204-85, 9204-89, 9303.13, and 9202-11. Address reprint requests to Mario Clerici, MD, Cuttedru di Inmunologiu, Universith degli Studi di Milano, Via Veneziun, I , 20133 Miluno, Ituly. The publication costs of this urticle were defruyed in part by puge charge payment. This article must therefore he hereby murked "advertisement" in accordance with 18 U.S.C. section I734 solely t~ indicate this fuct.
syncitium-inducing HIV strains is associated with the weakest type 1 cytokine production, the strongest type 2 cytokine production, and lowest CD4 counts. Additionally, it was determined that the interleukin (IL)-IO/IL-2 ratio best discriminates among different virologic scenarios. These data s u g gest that the virologic and immunologic correlates of disease protection and progression might be associated variables that define two different subsets of HIV' individuals and lend support to a viro-immunologic hypothesis of HIV infection. 0 1996 by The American Society of Hematology.
antigens precedes and heralds the development of opportunistic infections and Analogously, defective production of the CMI-inducing cytokines interleukin (1L)-2, 1L-12, and gamma interferon (1FN-y) and augmented production of type 2 cytokines IL-4, IL-5, IL-6, and IL-I0 are observed in HIV infection and have been proposed as an in vitro immunologic marker of progression in HIV' individuals, 11)-12
Because possible correlations between these virologic and immunologic parameters of protection and progression have not been established, we cross-sectionally analyzed HIV isolates and cytokine production in 63 consecutively enrolled HTV' individuals. Additionally, we analyzed which reciprocal pair of type 1 and type 2 cytokine is better capable to discriminate among HIV' individuals with different virologic characteristics.
MATERIALS AND METHODS

Purienrs und controls.
We analyzed virologic and immunologic parameters in 63 consecutively enrolled HIV-infected individuals treated at our outpatient clinic. Active drug users, as well as patients with overt AIDS according to the 1987 Centers for Disease Control (CDC) classification were not included in this study. Of the enrolled individuals, 58 were asymptomatic and five mildly symptomatic with constitutional symptoms or minor opportunistic infections (Group IVA or IV C2). Tdbk I shows the clinical and demographic features of the population studied. A total of 24 H I V~ healthy individuals were tested in parallel.
Peripheral blood mononuclear cells (PBMC) from H I V~ healthy individuals were stimulated for 24 to 48 hours with phytohemagglutinin P (PHA, lrvine Scientific, Irvine, CA). A total of 2 x IO" cells were cocultured with 2 X 10' cells from HIV' patients for 3 weeks in RPMI medium supplemented with 20% fetal calf serum and 10% recombinant IL-2 (Biosource International. Camarillo, CA). Supernatants were sampled twice a week and tested for p24 antigen production using a commercial enzyme-linked immunosorbent assay (ELISA). Once a week, fresh 2-day PHA-prestimulated donor cells were added to the cultures, maintaining a I : I ratio. A culture was considered positive if two serial supernatant samples were positive and showed a IO-fold increase in p24 antigen.
Each week, the viral cultures were tested for syncytia formation using the MT-2 assay, as described." Briefly. 
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(GIBCO) diluted 1:lOO at 37°C in a moist, 7% C 0 2 atmosphere. Stimulation with a mitogen was chosen because soluble antigens do not induce the production of quantities of m y , IL-4, and IL-IO sufficient to be detectable with current ELISA p r o t o c~l s '~ and to allow the comparison of these results to those obtained in previous st~dies.'~,'' Supematants were harvested after 48 hours (kinetic studies indicated that 48 hours was the optimal time for assessing PHAstimulated lymphokines prod~ction).'~ IL-2, IFNy, IL-4, and IL-IO production was evaluated with commercially available ELISA assays: IL-2: human IL-2 Quantikine (R&D Systems, Minneapolis, MN); IFNy: human interferon gamma Intertest y (Genzyme, Cambridge, MA); IL-4: human IL-4 Intertest-4 (Genzyme); IL-IO: human IL-10 ELISA (Bender MedSystems, Vienna, Austria) following the procedures suggested by the manufacturers. Cytokine production was calculated from a standard curve of the corresponding recombinant human cytokine.
Statistical analyses. To analyze differences in the HIV replication rate, we used a two-tailed t test for two samples, with equal variance assumed. Differences in immunologic variables between HC and HIV' individuals classified according to virus isolation and phenotype were analyzed using a distribution-free Kruskal-Wallis test (non-parametric one-way analysis of variance).I6 Possible relationships between immunologic parameters and the increasing severity of virologic results (considering the isolation negative situation the most benign one, and the one in which SI virus is isolated the least favorable one) were evaluated in HIV+ individuals by using a non-parametric Kendall's rank correlation."^" Because the infonna- Immunologic and statistical analyses. Mitogen-stimulated and unstimulated type 1 and type 2 cytokine production by PBMC was examined in the same patients and in 24 healthy controls. Unstimulated cytokine production was constantly less that 5% of the mitogen-stimulated value for each cytokine and was subtracted by all the results shown. IL-2, IFNy, IL-4, and IL-10 production is shown as box plots in Fig 2. The results of the analyses and summary statistics are shown in Table 2 . According to the results of Kruskal-Wallis tests, important differences between the individuals classified according to HIV positivity, isolation of HIV, and identification of SI variants were observed for all immunologic variables with the exception of p2. Also, a relationship between the severity of the virologic status in HIV' subjects, as inferred by the isolation of the virus and the presence of SI variants, was evident for all immunologic variables, again with the exception of p2. Thus, mitogen-stimulated production of the type 1 cytokines IL-2 and IFNy was significantly reduced in parallel with the increasing severity of the viral results, whereas mitogen-stimulated production of the type 2 cytokines IL-4 and IL-10 was significantly increased in parallel with the increasing severity of the viral results and the reduction of CD4 counts (Kendall's rank correlation). The median production of 1L-2 and IFNy was higher in the healthy controls than in all groups of HIV+ subjects, whereas the median production of IL-4 and IL-10 was lower in HIV+ isolation-negative subjects compared with all other HIV' individuals. Discriminating value of tjpe I and tjpe 2 cytokines. IL-2 and IL-IO (square-root transformed) resulted in the best discriminating variables. The best discrimination resulted in the direction of the dotted line in Fig 3A, where values of IL-2 were weighted about two times the values of IL-IO (score = JIL-10 -1.9.dIL-2 = JIL-10 -2.dIL-2; note the opposite sign assigned to IL-2 and IL-IO). However, the best discriminant function in HIV+ individuals is given by simply subtracting JIL-2 from hL-10 (score = JIL-10 -JIL-2; dashed line in Fig 3A) . According to the computed scores, only 56.3% of all subjects and 58.7% of HIV' subjects were correctly classified. However, ordering the virologic classes from the healthy controls to HlV+ individuals in whom SI HIV variants are isolated (individuals with the most severe virologic status), only two of 87 individuals were misplaced by more than one class. Moreover, both the scores appeared to separate completely HIV+ individuals in whom SI HIV use only. 1 IL-lOAl + IL-2), to avoid 1/0 ratios.
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variants were isolated from HC (Fig 3B) . 
DISCUSSION
Because HIV infection was suggested to be an immunovirologic disease, we analyzed possible correlations between HIV intrinsic biological properties, such as the rate and the extent of viral replication and viral phenotype and the strength and the quality of the immune response. Our hypotheses were two: (1) a tight correlation exists between the immunologic and the virologic aspects of HIV infection; and (2) the virologically most favorable outcome (inability to isolate HIV from PBMC) is associated with the strongest production of type 1 cytokines, the weakest production of type 2 cytokines, and the highest CD4 counts, whereas the virologically least favorable outcome (isolation of fast-replicating SI HIV variants) is associated with a specular immunologic situation (ie, defective production of type 1 cytokines, strong production of type 2 cytokines, and lowest CD4 counts). Thus, we cross-sectionally analyzed the rate and extent of HIV replication, HIV phenotype, cytokine production, and CD4 counts in 63 consecutively enrolled HIV+ individuals, and we examined cytokine production in 24 HIV-HC. The results suggest that the virologic and immunologic aspects of HIV infection are likely to be correlated. Therefore, the most dramatic reduction of type 1 cytokine production, as well as the greatest increment in type 2 cytokine production and the lowest CD4 counts are observed in those HIV+ individuals in whom fast-replicating SI HIV variants are isolated. Additionally, the IL-lO/IL-2 ratio is capable of the best correlation with viral parameters, ie, in vitro viral replication of fully infectious virions and ability to induce a cytopathic effect (SI variants). Virologic and immunologic correlates of disease activity have been proposed in HIV infection. Analyses of virologic correlates have indicated that the rate and the extent of HIV isolation in in vitro cultures of lymphocytes increase in the progression of the di~ease.''~'~ Thus, it was recently observed that HIV isolation by PBMC of long-term nonprogressing individuals (LTNP) is difficult, and is in some cases, possible only following depletion of CD8 lymphocytes."-" Plasma levels of HIV RNA, specific intracellular transcripts, and the number of PBMC containing integrated viral DNA are uniformly reduced in LTNP.zo-2' Additionally, a correlation exists between the emergence of HIV SI HIV strains and disease progression. Thus, ( 1 ) HIV SI variants are isolated in SO% to 60% of HIV' individuals with AIDS, but in less than 10% of HIV' asymptomatic individuals'; (2) 71% of HIV' individuals in whom SI HIV variants could be isolated, but only 16% of HIV' individuals in whom SI variants could not be isolated progressed to AIDS in a 30-month followup period'; and (3) the isolation of HIV SI variants is associated with increased decline in CD4+ T lymphocytes. 24 Immunological correlates of disease progression include abnormalities affecting both humoral and cell-mediated immunity. Thus, it was shown that antibodies with better neutralizing ability for laboratory and primary isolates are present in LTNP and that the antibody repertoire of these individuals is directed toward multiple HIV epitopes." We have proposed progressive impairment of type 1 cytokinedriven cell-mediated immunity to be the main immunologic correlate of disease progression.""' This hypothesis is based on different independent observations: (1) the gradual reduction of the ability of PBMC to produce IL-2, IL-12, and IFNy (type 1 cytokines) is accompanied in the progression of HIV infection by an increased generation of IL-4, IL-6, and IL-10 (type 2 ~y t o k i n e s )~"~" .~~;
(2) cytokine production profile of HIV+ LTNP individuals is characterized as high IL-2, high IFNyllow IL-4, low IL-10, whereas the cytokine production profile of HIV+ individuals with progressive HIV infection is exactly specular (low IL-2, low IFNylhigh IL-4, high IL-10)"; and (3) better preserved generation of HIVspecific cytotoxic T lymphocyte and HIV-specific T-cell proliferation are observed in HIV' LTNP Immunologic surrogate markers of disease progression include defective antigen-and mitogen-stimulated IL-2 production, which is predictive for subsequent decrease in CD4 counts, time to AIDS, and time to death" and is correlated in pediatric HIV infection with increased incidence of opportunistic infections.** Other markers of progression are the loss of the ability to elicit a DTH reaction to ubiquitous antigens (secondary to defective IL-2 production)x,'; hyperIgE (secondary to increased IL-4 production)*'^'"; and hypereosynophilia (secondary to increased IL-S production).3'.'' Thus, numerous virologic and immunologic markers of disease progression have been reported. Nevertheless, no complete analysis of the possible correlations between these two groups of correlates has been performed. We report here that the immunology and the virology of HIV infection are likely to be connected. Therefore, the worst possible outcome of virus analysis (isolation of fast-replicating SI HIV variants) is correlated with the least favorable immunologic results (defective type 1 cytokines/increased type 2 cytokines; reduced CD4 counts). Additionally, we show that the simple evaluation of the ratio between two cytokines (IL-10 and IL-2) is capable of completely discriminating among HIV' individuals with different virologic profiles and who are likely to have different prognoses.
Because these results stem from a cross-sectional analysis, we cannot evaluate whether the emergence of SI HIV variants is subsequent to the qualitative impairment of the immune response, or conversely, if the appearance of SI HIV use only. 
